• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化化疗诱导的胃肠道黏膜炎微生物干预措施的陷阱与新型实验方法

Pitfalls and novel experimental approaches to optimize microbial interventions for chemotherapy-induced gastrointestinal mucositis.

作者信息

da Silva Ferreira Ana R, Wardill Hannah R, Tissing Wim J E, Harmsen Hermie J M

机构信息

Department of Medical Microbiology.

Department of Pediatrics Oncology, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

出版信息

Curr Opin Support Palliat Care. 2020 Jun;14(2):127-134. doi: 10.1097/SPC.0000000000000497.

DOI:10.1097/SPC.0000000000000497
PMID:32324645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7259380/
Abstract

PURPOSE OF REVIEW

There is a growing number of studies implicating gut dysbiosis in mucositis development. However, few studies have shed light on the causal relationship limiting translational potential. Here, we detail the key supportive evidence for microbial involvement, candidate mechanisms by which the microbiome may contribute to mucositis and emerging approaches to model host-microbe interactions with clinical relevance and translational potential.

RECENT FINDINGS

Synthesis of existing clinical data demonstrate that modulating the microbiome drastically alters the development and severity of mucositis, providing a strong rationale for its involvement. Review of the literature revealed potential microbiome-dependent mechanisms of mucosal injury including altered drug metabolism, bile acid synthesis and regulation of the intestinal barrier. Current studies are limited in their mechanistic insight due to cross-sectional and would benefit from longitudinal analyses and baseline phenotyping.

SUMMARY

The causative role of the microbiome in mucositis development remains unclear. Future studies must adopt comprehensive microbial analyses with functional assessment, and utilize emerging ex-vivo models to interrogate host-microbe interactions in mucositis.

摘要

综述目的

越来越多的研究表明肠道微生物群失调与粘膜炎的发生有关。然而,很少有研究阐明这种因果关系,限制了其转化潜力。在此,我们详细阐述了微生物参与的关键支持证据、微生物群可能导致粘膜炎的候选机制,以及模拟具有临床相关性和转化潜力的宿主-微生物相互作用的新方法。

最新发现

现有临床数据的综合分析表明,调节微生物群会显著改变粘膜炎的发生和严重程度,这为其参与提供了有力的理论依据。文献综述揭示了潜在的微生物群依赖性粘膜损伤机制,包括药物代谢改变、胆汁酸合成和肠道屏障调节。由于目前的研究是横断面的,其机制洞察力有限,纵向分析和基线表型分析将有助于这些研究。

总结

微生物群在粘膜炎发生中的因果作用仍不清楚。未来的研究必须采用全面的微生物分析和功能评估,并利用新出现的体外模型来研究粘膜炎中的宿主-微生物相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4ec/7259380/f4eb187f3545/cospa-14-127-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4ec/7259380/ca9b7eaa5fef/cospa-14-127-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4ec/7259380/f4eb187f3545/cospa-14-127-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4ec/7259380/ca9b7eaa5fef/cospa-14-127-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4ec/7259380/f4eb187f3545/cospa-14-127-g002.jpg

相似文献

1
Pitfalls and novel experimental approaches to optimize microbial interventions for chemotherapy-induced gastrointestinal mucositis.优化化疗诱导的胃肠道黏膜炎微生物干预措施的陷阱与新型实验方法
Curr Opin Support Palliat Care. 2020 Jun;14(2):127-134. doi: 10.1097/SPC.0000000000000497.
2
New therapeutic strategies for combatting gastrointestinal toxicity.治疗胃肠道毒性的新策略。
Curr Opin Support Palliat Care. 2020 Jun;14(2):142-152. doi: 10.1097/SPC.0000000000000500.
3
Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity.Toll样受体在化疗诱导的胃肠道毒性发病机制中的作用
Curr Opin Support Palliat Care. 2016 Jun;10(2):157-64. doi: 10.1097/SPC.0000000000000202.
4
The role of mucins in mucositis.黏蛋白在黏膜炎中的作用。
Curr Opin Support Palliat Care. 2019 Jun;13(2):114-118. doi: 10.1097/SPC.0000000000000423.
5
Chemotherapy-driven dysbiosis in the intestinal microbiome.化疗引起的肠道微生物组失调。
Aliment Pharmacol Ther. 2015 Sep;42(5):515-28. doi: 10.1111/apt.13302. Epub 2015 Jul 6.
6
Role of mucositis in predicting gut microbiota composition in people with cancer.口腔黏膜炎在预测癌症患者肠道微生物组成中的作用。
Curr Opin Support Palliat Care. 2024 Jun 1;18(2):73-77. doi: 10.1097/SPC.0000000000000700. Epub 2024 Apr 23.
7
Chemotherapy-Induced Intestinal Microbiota Dysbiosis Impairs Mucosal Homeostasis by Modulating Toll-like Receptor Signaling Pathways.化疗诱导的肠道微生物失调通过调节 Toll 样受体信号通路损害黏膜稳态。
Int J Mol Sci. 2021 Aug 31;22(17):9474. doi: 10.3390/ijms22179474.
8
A More Robust Gut Microbiota in Calorie-Restricted Mice Is Associated with Attenuated Intestinal Injury Caused by the Chemotherapy Drug Cyclophosphamide.热量限制的小鼠中更为健壮的肠道微生物群与化疗药物环磷酰胺引起的肠道损伤减轻有关。
mBio. 2019 Mar 12;10(2):e02903-18. doi: 10.1128/mBio.02903-18.
9
The alterations of microbiota and pathological conditions in the gut of patients with colorectal cancer undergoing chemotherapy.结直肠癌化疗患者肠道微生物群和病理状况的改变。
Anaerobe. 2021 Apr;68:102361. doi: 10.1016/j.anaerobe.2021.102361. Epub 2021 Mar 26.
10
Radiotherapy and the gut microbiome: facts and fiction.放疗与肠道微生物组:事实与虚构。
Radiat Oncol. 2021 Jan 13;16(1):9. doi: 10.1186/s13014-020-01735-9.

引用本文的文献

1
Peach Gum Polysaccharide Prevents Chemotherapy-Induced Intestinal Injury and Degenerative Behavior.桃胶多糖可预防化疗引起的肠道损伤和退行性行为。
Integr Cancer Ther. 2025 Jan-Dec;24:15347354251368410. doi: 10.1177/15347354251368410. Epub 2025 Aug 23.
2
Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation.肠道微生物群作为抗癌治疗的新靶点:从作用机制到调控手段
NPJ Biofilms Microbiomes. 2025 Mar 11;11(1):43. doi: 10.1038/s41522-025-00678-x.
3
Important Role of Intestinal Microbiota in Chemotherapy-induced Diarrhea and Therapeutics.

本文引用的文献

1
Baseline microbiota composition modulates antibiotic-mediated effects on the gut microbiota and host.基础微生物组成调节抗生素对肠道微生物组和宿主的影响。
Microbiome. 2019 Aug 2;7(1):111. doi: 10.1186/s40168-019-0725-3.
2
The pathogenesis of mucositis: updated perspectives and emerging targets.黏膜炎发病机制:最新观点和新兴靶点。
Support Care Cancer. 2019 Oct;27(10):4023-4033. doi: 10.1007/s00520-019-04893-z. Epub 2019 Jul 8.
3
Antibiotics induced intestinal tight junction barrier dysfunction is associated with microbiota dysbiosis, activated NLRP3 inflammasome and autophagy.
肠道微生物群在化疗引起的腹泻及治疗中的重要作用
J Cancer. 2025 Jan 1;16(2):648-659. doi: 10.7150/jca.99421. eCollection 2025.
4
New Insights into the Relationship between Gut Microbiota and Radiotherapy for Cancer.肠道微生物群与癌症放射治疗关系的新见解。
Nutrients. 2022 Dec 22;15(1):48. doi: 10.3390/nu15010048.
5
PET/CT imaging detects intestinal inflammation in a mouse model of doxorubicin-induced mucositis.正电子发射断层扫描/计算机断层扫描(PET/CT)成像在阿霉素诱导的粘膜炎小鼠模型中检测到肠道炎症。
Front Oncol. 2022 Dec 15;12:1061804. doi: 10.3389/fonc.2022.1061804. eCollection 2022.
6
Chemotherapy induced gastrointestinal toxicities.化疗引起的胃肠道毒性。
Adv Cancer Res. 2022;155:131-166. doi: 10.1016/bs.acr.2022.02.007. Epub 2022 Mar 21.
7
Does Chemotherapy-Induced Gastrointestinal Mucositis Affect the Bioavailability and Efficacy of Anti-Infective Drugs?化疗引起的胃肠道黏膜炎会影响抗感染药物的生物利用度和疗效吗?
Biomedicines. 2021 Oct 4;9(10):1389. doi: 10.3390/biomedicines9101389.
8
Metagenomics and chemotherapy-induced nausea: A roadmap for future research.宏基因组学与化疗所致恶心:未来研究的路线图。
Cancer. 2022 Feb 1;128(3):461-470. doi: 10.1002/cncr.33892. Epub 2021 Oct 13.
抗生素诱导的肠道紧密连接屏障功能障碍与微生物失调、NLRP3 炎性小体激活和自噬有关。
PLoS One. 2019 Jun 18;14(6):e0218384. doi: 10.1371/journal.pone.0218384. eCollection 2019.
4
The role of mucins in mucositis.黏蛋白在黏膜炎中的作用。
Curr Opin Support Palliat Care. 2019 Jun;13(2):114-118. doi: 10.1097/SPC.0000000000000423.
5
Targeting neratinib-induced diarrhea with budesonide and colesevelam in a rat model.用布地奈德和考来烯胺靶向治疗奈拉替尼诱导的腹泻的大鼠模型。
Cancer Chemother Pharmacol. 2019 Mar;83(3):531-543. doi: 10.1007/s00280-018-3756-8. Epub 2018 Dec 10.
6
Mouse Microbiota Models: Comparing Germ-Free Mice and Antibiotics Treatment as Tools for Modifying Gut Bacteria.小鼠微生物群模型:比较无菌小鼠和抗生素治疗作为改变肠道细菌的工具
Front Physiol. 2018 Oct 31;9:1534. doi: 10.3389/fphys.2018.01534. eCollection 2018.
7
Impact of the Use and Type of Antibiotics on Acute Graft-versus-Host Disease.抗生素的使用和类型对急性移植物抗宿主病的影响。
Biol Blood Marrow Transplant. 2018 Nov;24(11):2178-2183. doi: 10.1016/j.bbmt.2018.06.031. Epub 2018 Jul 3.
8
The bidirectional interaction of the gut microbiome and the innate immune system: Implications for chemotherapy-induced gastrointestinal toxicity.肠道微生物组与先天免疫系统的双向相互作用:对化疗引起的胃肠道毒性的影响。
Int J Cancer. 2019 May 15;144(10):2365-2376. doi: 10.1002/ijc.31836. Epub 2018 Oct 1.
9
Mechanisms regulating intestinal barrier integrity and its pathological implications.调节肠道屏障完整性的机制及其病理意义。
Exp Mol Med. 2018 Aug 16;50(8):1-9. doi: 10.1038/s12276-018-0126-x.
10
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.药物微生物组学:在癌症治疗中利用药物-微生物群相互作用。
Microbiome. 2018 May 22;6(1):92. doi: 10.1186/s40168-018-0483-7.